The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Prevalence of Genital Human Papillomavirus Among Females in the United States, the National Health and Nutrition Examination Survey, 2003–2006
Abstract
BACKGROUND: Genital human papillomaviruses (HPV) include >40 sexually transmitted viruses. Most HPV infections do not progress to disease, but infection with certain types of HPV can cause cervical and other anogenital and oropharyngeal cancer, and other types of HPV are associated with anogenital warts. HPV vaccines prevent infection with HPV 16 and 18, which account for 70% of cases of cervical cancer, and HPV 6 and 11, which cause 90% of the cases of anogenital warts. METHODS: Using data and self-collected cervicovaginal specimens from 4150 females, 14-59 years of age, from consecutive National Health and Nutrition Examination Surveys (2003-2006), we estimated the prevalence of type-specific HPV DNA and examined sociodemographic and sexual determinants. RESULTS: The overall prevalence of HPV was 42.5% in females 14-59 years of age and varied significantly by age, race or ethnicity, and number of sex partners. Individual type prevalence was less than 7%, ranging from <0.5% through 6.5%. The most common type was nononcogenic HPV 62 (found in 6.5% of subjects), followed by HPV 53 and HPV 16 (4.7%), both of which are oncogenic types. The most prevalent species was nononcogenic α3. CONCLUSIONS: HPV infection is common among US females, with the highest burden of infection found in young females 20-24 years of age. Monitoring trends in HPV type distribution will contribute to our understanding of the early impact of HPV vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Casella, G., & Berger, R. (2024) · Chapman & Hall/CRC eBooks · doi:10.1201/9781003456285 · Cited by 5,711
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
Kreimer, A. R., Clifford, G. M., Boyle, P., & Franceschi, S. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0551 · Cited by 2,184
Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007) · PsycEXTRA Dataset · doi:10.1037/e601292007-001 · Cited by 1,882
Self-citationde Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N., & Bosch, F. X. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70158-5 · Cited by 1,669 · cited 1×
“The observed age distribution in this study supports the body of epidemiologic evidence that suggests that first HPV infection is acquired shortly after a woman becomes sexually active [20–22].”
ResultPaavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61248-4 · Cited by 1,655
Le, M. (2007) · Medical Entomology and Zoology · Cited by 1,624
Prevalence of HPV Infection Among Females in the United States
Dunne, E. F., Unger, E. R., Sternberg, M., McQuillan, G., Swan, D. C., Patel, S. S., & Markowitz, L. E. (2007) · JAMA · doi:10.1001/jama.297.8.813 · Cited by 1,579
Self-citationChapter 2: The burden of HPV-related cancers
Parkin, D. M., & Bray, F. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.111 · Cited by 1,385
Chapter 1: HPV in the etiology of human cancer
Muñoz, N., Castellsagué, X., de González, A. B., & Gissmann, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.115 · Cited by 1,355 · cited 1×
“closely related but genetically distinct sexually transmitted viruses that are usually classified as high-risk (HR) or low-risk (LR) according to their oncogenic potential [1–3].”
BackgroundEpidemiology of Genital Human Papillomavirus Infection
Koutsky, P. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,107
Clifford, G., Gallus, S., Herrero, R., Muñoz, N., Snijders, P., Vaccarella, S., Anh, P., Ferreccio, C., Hieu, N., Matos, E., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67069-9 · Cited by 1,093
Winer, R. L. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf180 · Cited by 1,044
Trends in Herpes Simplex Virus Type 1 and Type 2 Seroprevalence in the United States
Xu, F., Sternberg, M. R., Kottiri, B. J., McQuillan, G. M., Lee, F. K., Nahmias, A. J., Berman, S. M., & Markowitz, L. E. (2006) · JAMA · doi:10.1001/jama.296.8.964 · Cited by 1,035
Self-citationBosch, F. X., Burchell, A. N., Schiffman, M., Giuliano, A. R., de Sanjose, S., Bruni, L., Tortolero-Luna, G., Kjaer, S. K., & Muñoz, N. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.064 · Cited by 842
Design and estimation for the National Health Interview Survey, 1995-2004
Botman, S., & Moriarity, C. L. (2000) · Cited by 785
Lexau, C. A. (2005) · JAMA · doi:10.1001/jama.294.16.2043 · Cited by 671
Brown, D. R., Kjaer, S. K., Sigurdsson, K., Iversen, O., Hernandez‐Avila, M., Wheeler, C. M., Perez, G., Koutsky, L. A., Tay, E. H., Garcia, P., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597307 · Cited by 627
Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease
Lacey, C. J. N., Lowndes, C. M., & Shah, K. V. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.015 · Cited by 535
Epidemiologic studies utilizing surveys: accounting for the sampling design.
Korn, E. L., & Graubard, B. I. (1991) · American Journal of Public Health · doi:10.2105/ajph.81.9.1166 · Cited by 490
Schiffman, M., Clifford, G., & Buonaguro, F. M. (2009) · Infectious Agents and Cancer · doi:10.1186/1750-9378-4-8 · Cited by 448
The carcinogenicity of human papillomavirus types reflects viral evolution
Schiffman, M., Herrero, R., DeSalle, R., Hildesheim, A., Wacholder, S., Cecilia Rodriguez, A., Bratti, M. C., Sherman, M. E., Morales, J., Guillen, D., et al. (2005) · Virology · doi:10.1016/j.virol.2005.04.002 · Cited by 441
Carriage of pneumococci after pneumococcal vaccination
Obaro, S. K., Adegbola, R., Banya, W., & Greenwood, B. (1996) · The Lancet · doi:10.1016/s0140-6736(05)65585-7 · Cited by 325
Liaw, K., Hildesheim, A., Burk, R. D., Gravitt, P., Wacholder, S., Manos, M. M., Scott, D. R., Sherman, M. E., Kurman, R. J., Glass, A. G., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/317638 · Cited by 291
Petignat, P., Faltin, D. L., Bruchim, I., Tramèr, M. R., Franco, E. L., & Coutlée, F. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.01.023 · Cited by 290
Markowitz, L. E., Sternberg, M., Dunne, E. F., McQuillan, G., & Unger, E. R. (2009) · The Journal of Infectious Diseases · doi:10.1086/604729 · Cited by 188
Self-citationGravitt, P. E., Lacey, J. V., Brinton, L. A., Barnes, W. A., Kornegay, J., Greenberg, M., Greene, S. M., Hadjimichael, O. C., McGowan, L., Mortel, R., et al. (2001) · PubMed · Cited by 139
Castle, P. E., Gravitt, P. E., Solomon, D., Wheeler, C. M., & SCHIFFMAN, M. H. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01667-07 · Cited by 106
A Comparison of Cervical and Vaginal Human Papillomavirus
Castle, P. E., Rodríguez, A. C., Porras, C., Herrero, R., SCHIFFMAN, M. H., González, P., Hildesheim, A., & Burk, R. D. (2007) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318064c8c5 · Cited by 91
Dunne, E. F., Sternberg, M., Markowitz, L. E., McQuillan, G. M., Swan, D., Patel, S. S., & Unger, E. R. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir342 · Cited by 67
Self-citationHuman papilloma virus infection prior to coitarche
Dörfler, D., Bernhaus, A., Kottmel, A., Sam, C. E., Koelle, D., & Joura, E. A. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.12.028 · Cited by 49
A real-time PCR assay for HPV52 detection and viral load quantification.
Onyekwuluje, J., Steinau, M., Swan, D. C., & Unger, E. R. (2012) · PubMed · Cited by 43
Self-citationWiner, R. L., Hughes, J. P., Feng, Q., O’Reilly, S. F., Kiviat, N. B., & Koutsky, L. A. (2009) · The Journal of Infectious Diseases · doi:10.1086/597118 · Cited by 28
Impact of HPV Assay on Observed Population Prevalence
Unger, E. R., Steinau, M., Lin, J.-M. S., Patel, S. S., & Swan, D. C. (2011) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e3181f56fa5 · Cited by 6
Self-citation
Cited by
Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008
Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., Ocfemia, M. C. B., Su, J., Xu, F., & Weinstock, H. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318286bb53 · Cited by 1,260
Self-citationPrevalence of Oral HPV Infection in the United States, 2009-2010
Gillison, M. L., Broutian, T., Pickard, R. K. L., Tong, Z.-Y., Xiao, W., Kahle, L., Graubard, B. I., & Chaturvedi, A. K. (2012) · JAMA · doi:10.1001/jama.2012.101 · Cited by 1,064
Holman, D. M., Benard, V., Roland, K. B., Watson, M., Liddon, N., & Stokley, S. (2014) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2013.2752 · Cited by 863
The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States
Chesson, H. W., Dunne, E. F., Hariri, S., & Markowitz, L. E. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000193 · Cited by 706
Self-citationBreast Cancer Epidemiology, Prevention, and Screening
Winters, S., Martin, C., Murphy, D., & Shokar, N. K. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.07.002 · Cited by 667
Metadata
- Authors
- Hariri, S., Unger, E. R., Sternberg, M., Dunne, E. F., Swan, D., Patel, S., & Markowitz, L. E.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-08-15
- Volume
- 204
- Issue
- 4
- Pages
- 566-573
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2151799839
- Cited by
- 380
- References
- 36
- FWCI
- 27.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.